Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
HLX-0201 was then validated in preclinical models of fragile X, where it was found to modify several behaviours similar to those that are exhibited in patients with the condition.
Lead Product(s): HLX-0201
Therapeutic Area: Genetic Disease Product Name: HLX-0201
Highest Development Status: IND EnablingProduct Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable October 20, 2021